BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32329899)

  • 21. Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.
    Patel HD; Gupta M; Joice GA; Srivastava A; Alam R; Allaf ME; Pierorazio PM
    Eur Urol Oncol; 2019 Jul; 2(4):343-348. PubMed ID: 31277771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.
    Kuusk T; De Bruijn R; Brouwer OR; De Jong J; Donswijk M; Hendricksen K; Horenblas S; Jóźwiak K; Prevoo W; Valdés Olmos RA; Van Der Poel HG; Van Rhijn BW; Wit EM; Bex A
    Scand J Urol; 2018; 52(5-6):411-418. PubMed ID: 30526184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program.
    Liao X; Qiu S; Zheng X; Ai J; Jin X; Gong L; Bao Y; Jin K; Li H; Yang L; Wei Q
    Clin Genitourin Cancer; 2019 Oct; 17(5):e968-e980. PubMed ID: 31229458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.
    Saltzman AF; Stokes W; Walker J; Cost NG
    J Pediatr Urol; 2019 May; 15(3):259.e1-259.e7. PubMed ID: 30819622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?
    Demir T; Aliyev A; Beşiroğlu M; Araz M; Köstek O; Sakin A; Shbair ATM; Çoban G; Ersöz C; Şeker M; Türk HM
    Curr Probl Cancer; 2021 Feb; 45(1):100619. PubMed ID: 32800688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
    Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
    Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma.
    Shao N; Wang HK; Zhu Y; Ye DW
    Cancer Med; 2018 Nov; 7(11):5431-5438. PubMed ID: 30306741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
    Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz B; Belldegrun AS; Figlin RA
    Cancer; 2003 Jun; 97(12):2995-3002. PubMed ID: 12784334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
    Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
    Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
    Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
    Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
    Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
    Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.
    Geller JI; Dome JS
    Cancer; 2004 Oct; 101(7):1575-83. PubMed ID: 15378495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
    Morgan TM; Tang D; Stratton KL; Barocas DA; Anderson CB; Gregg JR; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
    Eur Urol; 2011 Jun; 59(6):923-8. PubMed ID: 21295907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy.
    Luo JH; Zhou FJ; Xie D; Zhang ZL; Liao B; Zhao HW; Dai YP; Chen LW; Chen W
    World J Urol; 2010 Jun; 28(3):289-93. PubMed ID: 19916010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.